Dermal Fillers Market size is expected to grow at a CAGR of 7.5% through the forecast period
Dermal Fillers Market was valued at US$ 5.37 Bn. in 2023. Dermal Fillers Market size is expected to grow at a CAGR of 7.5% through the forecast period.
(EMAILWIRE.COM, August 31, 2024 ) The Dermal Fillers Market was valued at USD 5.37 Bn. in 2023, and expected to reach USD 8.91 Bn. in 2030. Dermal Fillers Market size is expected to grow at a CAGR of 7.5% through the forecast period.
The growing desire for non-invasive or minimally invasive cosmetic operations is driving the global dermal fillers market, which includes males in all demographic groups. Remarkably, men were treated with hyaluronic acid in 12.2% of non-surgical cases. The dermal fillers market is expected to grow at a 7.5% CAGR in Europe and 45% in North America in 2023, with high costs and practitioner credentials having an impact on the latter. In 2023, 15.6 million cosmetic treatments were performed in the US.
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/73650/
Dermal Fillers Market Segmentation
by Material
Hyaluronic Acid
Calcium Hydroxyapatite
Poly-L-Latic Acid
PMMA
Fat Fillers
Others
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/73650/
by Product
Biodegradable
Non-Biodegradable
by Application Scar Treatment
Wrinkle Correction Treatment
Lip Enhancement
Restoration of Volume/Fullness
Others
by End-User
Specialty & Dermatology Clinics
Hospitals & Clinics
Others
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/73650/
Dermal Fillers Market Key Players:
ALLERGAN (AbbVie, Inc.) (U.S.)
Revance Therapeutics, Inc. (U.S.)
Merz Pharma (Germany)
Galderma (Switzerland)
SCULPT Luxury Dermal Fillers LTD (Czech Republic)
Maximize Market Research is leading Healthcare research firm, has also published the following reports:
Hyperuricemia Drugs Market size was valued at USD 5.08 Billion in 2023 and the total Hyperuricemia Drugs Market revenue is expected to grow at a CAGR of 8.52% from 2024 to 2030, reaching nearly USD 9.00 Billion by 2030.
Intratumoral Cancer Therapy Market size was valued at USD 210.07 Billion in 2023 and the total Intratumoral Cancer Therapy Market revenue is expected to grow at a CAGR of 9.7% from 2024 to 2030, reaching nearly USD 410.62 Billion by 2030.
About Maximize Market Research
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and communications, Internet of Things, Food and Beverages, Aerospace and defense, and other manufacturing sectors.
The growing desire for non-invasive or minimally invasive cosmetic operations is driving the global dermal fillers market, which includes males in all demographic groups. Remarkably, men were treated with hyaluronic acid in 12.2% of non-surgical cases. The dermal fillers market is expected to grow at a 7.5% CAGR in Europe and 45% in North America in 2023, with high costs and practitioner credentials having an impact on the latter. In 2023, 15.6 million cosmetic treatments were performed in the US.
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/73650/
Dermal Fillers Market Segmentation
by Material
Hyaluronic Acid
Calcium Hydroxyapatite
Poly-L-Latic Acid
PMMA
Fat Fillers
Others
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/73650/
by Product
Biodegradable
Non-Biodegradable
by Application Scar Treatment
Wrinkle Correction Treatment
Lip Enhancement
Restoration of Volume/Fullness
Others
by End-User
Specialty & Dermatology Clinics
Hospitals & Clinics
Others
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/73650/
Dermal Fillers Market Key Players:
ALLERGAN (AbbVie, Inc.) (U.S.)
Revance Therapeutics, Inc. (U.S.)
Merz Pharma (Germany)
Galderma (Switzerland)
SCULPT Luxury Dermal Fillers LTD (Czech Republic)
Maximize Market Research is leading Healthcare research firm, has also published the following reports:
Hyperuricemia Drugs Market size was valued at USD 5.08 Billion in 2023 and the total Hyperuricemia Drugs Market revenue is expected to grow at a CAGR of 8.52% from 2024 to 2030, reaching nearly USD 9.00 Billion by 2030.
Intratumoral Cancer Therapy Market size was valued at USD 210.07 Billion in 2023 and the total Intratumoral Cancer Therapy Market revenue is expected to grow at a CAGR of 9.7% from 2024 to 2030, reaching nearly USD 410.62 Billion by 2030.
About Maximize Market Research
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and communications, Internet of Things, Food and Beverages, Aerospace and defense, and other manufacturing sectors.
Contact Information:
MAXIMIZE MARKET RESEARCH PVT. LTD.
L Godage
Tel: 09607365656
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
MAXIMIZE MARKET RESEARCH PVT. LTD.
L Godage
Tel: 09607365656
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results